Vanguard Health Care Index Fund
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
SOURCE: MARKET TAPE & DAILY CREATION/REDEMPTION RECORDS · 3Y SHOWN · NET −$134M OVER THIS RANGE
Flows are quiet — the past month netted out near zero, while the price has returned +14.1% so far this year. At 0.10% a year it is not the cheapest way in — XLV runs the same ground at 0.09%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS TODAY’S MOVE · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | LLYELI LILLY | 13.40% | $1226.44 | +3.6% | ||
| 2 | JNJJOHNSON & JOHNSON | 8.84% | $271.02 | +3.2% | ||
| 3 | ABBVABBVIE | 6.45% | $258.97 | +3.4% | ||
| 4 | UNHUNITEDHEALTH GROUP | 5.46% | $393.66 | -0.5% | ||
| 5 | MRKMERCK & CO | 4.68% | $135.12 | -0.6% | ||
| 6 | AMGNAMGEN | 3.02% | $425.24 | +1.6% | ||
| 7 | TMOTHERMO FISHER SCIENTIFIC | 3.10% | $589.64 | +0.7% | ||
| 8 | ABTABBOTT LABORATORIES | 2.67% | $112.69 | +2.1% | ||
| 9 | GILDGILEAD SCIENCES | 2.35% | $143.35 | +3.2% | ||
| 10 | PFEPFIZER | 2.07% | $27.26 | +1.4% | ||
| 11 | ISRGINTUITIVE SURGICAL | 1.82% | $390.98 | +0.2% | ||
| 12 | BMYBRISTOL MYERS SQUIBB | 1.94% | $66.10 | +2.1% | ||
| 13 | VRTXVERTEX PHARMACEUTICALS | 1.76% | $528.64 | +2.6% | ||
| 14 | DHRDANAHER | 1.80% | $199.51 | -1.6% | ||
| 15 | CVSCVS | 1.93% | $94.88 | +1.0% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus CSV export, watchlists, and flow alerts — unlock across the network.
Sign in to see all 412| 1 week | +4.0% |
| 1 month | +8.6% |
| 3 months | +21.4% |
| 6 months | +13.5% |
| YTD | +14.1% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The top holding is 13.4% of the book; the top ten carry 52%. Spread across 250+ names, it behaves like roughly 23 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $41M | $29M |
| JNJ JOHNSON & JOHNSON | $18M | $18M |
| UNH UNITEDHEALTH GROUP | $11M | $13M |
| ABBV ABBVIE | $8M | $7M |
| AMGN AMGEN | $5M | $5M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat VHT on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $128.4B | +$547M | -5bp on fee · 7× the assets · +$547M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.7B | +$104M | -6bp on fee · 2× the assets · +$104M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.4B | +$520M | -6bp on fee · +$520M in over the month | Head-to-head |
| IGIB iShares 5-10 Year Investment Grade Corporate Bond ETF | 0.04% | $18.7B | +$312M | -6bp on fee · +$312M in over the month | Head-to-head |
| IEFA iShares Core MSCI EAFE ETF | 0.07% | $195.3B | +$631M | -3bp on fee · 10× the assets · +$631M in over the month | Head-to-head |